Abbott unveils AVEIR DR leadless pacemaker system with CE Mark approval in Europe
Abbott has achieved a significant milestone in cardiac healthcare by securing the CE Mark for its AVEIR dual chamber (DR) leadless pacemaker system in Europe. ... Read More
Abbott launches GLP Systems Track lab automation system in US
Abbott has announced the launch of its innovative lab automation solution, GLP systems Track, which has recently received approval from the U.S. Food and Drug ... Read More
Abbott secures Bigfoot Biomedical to boost diabetes care tech
Abbott has wrapped up the previously announced acquisition of Bigfoot Biomedical. The latter which is a Silicon Valley-based front-runner is celebrated for its revolutionary smart ... Read More
Abbott closes $890m acquisition of Cardiovascular Systems
Abbott has closed the previously announced $890 million acquisition of Cardiovascular Systems, Inc. (CSI), which has developed an atherectomy system for the treatment of peripheral ... Read More
Generic Pharmasec to distribute Abbott Point of Care’s products in India
Generic Pharmasec said that it has signed an agreement with Abbott Point of Care (APOC) for the distribution, marketing, and promotion of the latter’s full ... Read More
AstraZeneca India scraps Dapagliflozin distribution deal with Abbott
AstraZeneca Pharma India (AstraZeneca India) said that it has scrapped its distribution agreement with Abbott Healthcare pertaining to its Type 2 diabetes drug Dapagliflozin in ... Read More
Abbott gets FDA EUA for COVID-19 antibody blood test on Alinity i system
Abbott has been granted emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for its SARS-CoV-2 IgG lab-based serology blood test, a ... Read More
Abbott ID NOW COVID-19 test gets FDA nod to detect coronavirus in 5 mins
Abbott ID NOW COVID-19 test : Medical device company Abbott has been granted Emergency Use Authorization (EUA) for its five-minute novel coronavirus diagnostic test from ... Read More
CATALYST clinical trial : FDA approves Abbott’s trial of Amplatzer Amulet device in AF
Abbott has been granted approval from the US Food and Drug Administration (FDA) for the CATALYST clinical trial to assess its Amplatzer Amulet Left Atrial ... Read More